# ë§ŒíŒŒì‹ ê¸°ìˆ ë¬¸ì„œ(Technical File) ëª©ì°¨

> **ë¬¸ì„œ ID**: MPS-QMS-TFS-001
> **ì‘ì„±ì¼**: 2026-02-09
> **ì‘ì„±ì**: Claude (Regulatory & Security Analysis)
> **ì ìš© ëŒ€ìƒ**: FDA 510(k), CE-IVDR Annex II/III, MFDS ì²´ì™¸ì§„ë‹¨ê¸°ê¸° í—ˆê°€, NMPA, PMDA

---

## 1. ê³µí†µ ê¸°ìˆ ë¬¸ì„œ ë§ˆìŠ¤í„° êµ¬ì¡°

```
docs/technical-file/
â”‚
â”œâ”€â”€ 01-device-description/                    # ê¸°ê¸° ì„¤ëª…
â”‚   â”œâ”€â”€ 01-product-overview.md                # ì œí’ˆ ê°œìš” ë° ì˜ë„ëœ ì‚¬ìš©
â”‚   â”œâ”€â”€ 02-system-architecture.md             # ì‹œìŠ¤í…œ ì•„í‚¤í…ì²˜ (HW + SW + Cloud)
â”‚   â”œâ”€â”€ 03-functional-description.md          # ê¸°ëŠ¥ ì„¤ëª… (ì°¨ë™ì¸¡ì •, í•‘ê±°í”„ë¦°íŠ¸, AI)
â”‚   â”œâ”€â”€ 04-hardware-description.md            # ë¦¬ë”ê¸° í•˜ë“œì›¨ì–´ ì„¤ëª…
â”‚   â”œâ”€â”€ 05-software-description.md            # ì†Œí”„íŠ¸ì›¨ì–´ ì„¤ëª… (ì•„í‚¤í…ì²˜, ëª¨ë“ˆ, ë²„ì „)
â”‚   â”œâ”€â”€ 06-cartridge-system.md                # 29ì¢… ì¹´íŠ¸ë¦¬ì§€ ì‹œìŠ¤í…œ ìƒì„¸
â”‚   â”œâ”€â”€ 07-accessories-and-components.md      # ë¶€ì†í’ˆ ë° êµ¬ì„±í’ˆ ëª©ë¡
â”‚   â””â”€â”€ 08-comparison-with-predicate.md       # ìœ ì‚¬ ê¸°ê¸° ë¹„êµ (510(k)ìš©)
â”‚
â”œâ”€â”€ 02-design-and-manufacturing/              # ì„¤ê³„ ë° ì œì¡°
â”‚   â”œâ”€â”€ 01-design-input.md                    # ì„¤ê³„ ì…ë ¥ (ìš”êµ¬ì‚¬í•­)
â”‚   â”œâ”€â”€ 02-design-output.md                   # ì„¤ê³„ ì¶œë ¥ (ì•„í‚¤í…ì²˜, ì½”ë“œ, ë¬¸ì„œ)
â”‚   â”œâ”€â”€ 03-design-review-records.md           # ì„¤ê³„ ê²€í†  ê¸°ë¡
â”‚   â”œâ”€â”€ 04-design-transfer.md                 # ì„¤ê³„ ì´ê´€ (ê°œë°œâ†’ì œì¡°)
â”‚   â”œâ”€â”€ 05-design-changes.md                  # ì„¤ê³„ ë³€ê²½ ì´ë ¥
â”‚   â””â”€â”€ 06-manufacturing-process.md           # ì œì¡° í”„ë¡œì„¸ìŠ¤ (ì¹´íŠ¸ë¦¬ì§€, ë¦¬ë”ê¸°)
â”‚
â”œâ”€â”€ 03-software-documentation/                # ì†Œí”„íŠ¸ì›¨ì–´ ë¬¸ì„œ (IEC 62304)
â”‚   â”œâ”€â”€ 01-software-development-plan.md       # ì†Œí”„íŠ¸ì›¨ì–´ ê°œë°œ ê³„íš
â”‚   â”œâ”€â”€ 02-software-requirements-spec.md      # SRS (ì†Œí”„íŠ¸ì›¨ì–´ ìš”êµ¬ì‚¬í•­ ëª…ì„¸)
â”‚   â”œâ”€â”€ 03-software-architecture-doc.md       # SAD (ì†Œí”„íŠ¸ì›¨ì–´ ì•„í‚¤í…ì²˜ ì„¤ê³„)
â”‚   â”œâ”€â”€ 04-software-safety-classification.md  # â†’ ê¸°ì¡´ ì™„ë£Œ ë¬¸ì„œ ì°¸ì¡°
â”‚   â”œâ”€â”€ 05-subsystem-safety-allocation.md     # â†’ ê¸°ì¡´ ì™„ë£Œ ë¬¸ì„œ ì°¸ì¡° (ì„¹ì…˜ 5)
â”‚   â”œâ”€â”€ 06-unit-test-results.md               # ë‹¨ìœ„ í…ŒìŠ¤íŠ¸ ê²°ê³¼
â”‚   â”œâ”€â”€ 07-integration-test-plan.md           # í†µí•© í…ŒìŠ¤íŠ¸ ê³„íš ë° ê²°ê³¼
â”‚   â”œâ”€â”€ 08-system-test-plan.md                # ì‹œìŠ¤í…œ í…ŒìŠ¤íŠ¸ ê³„íš ë° ê²°ê³¼
â”‚   â”œâ”€â”€ 09-traceability-matrix.md             # ì¶”ì ì„± ë§¤íŠ¸ë¦­ìŠ¤ (ìš”êµ¬ì‚¬í•­â†”ì„¤ê³„â†”í…ŒìŠ¤íŠ¸â†”ì½”ë“œ)
â”‚   â”œâ”€â”€ 10-soup-list-and-assessment.md        # SOUP ëª©ë¡ ë° ìœ„í—˜ í‰ê°€
â”‚   â”œâ”€â”€ 11-anomaly-list.md                    # ì•Œë ¤ì§„ ì´ìƒ/ê²°í•¨ ëª©ë¡
â”‚   â””â”€â”€ 12-release-notes.md                   # ë¦´ë¦¬ìŠ¤ ë…¸íŠ¸
â”‚
â”œâ”€â”€ 04-risk-management/                       # ìœ„í—˜ê´€ë¦¬ (ISO 14971)
â”‚   â””â”€â”€ â†’ docs/risk-management/ ì°¸ì¡°          # ë³„ë„ ìœ„í—˜ê´€ë¦¬ íŒŒì¼ êµ¬ì¡° (10+4 ë¬¸ì„œ)
â”‚
â”œâ”€â”€ 05-verification-and-validation/           # ê²€ì¦ ë° í™•ì¸
â”‚   â”œâ”€â”€ 01-vv-master-plan.md                  # V&V ë§ˆìŠ¤í„° í”Œëœ
â”‚   â”œâ”€â”€ 02-analytical-performance.md          # ë¶„ì„ ì„±ëŠ¥ (ë¯¼ê°ë„, íŠ¹ì´ë„, ì •í™•ë„, ì •ë°€ë„)
â”‚   â”‚   â”œâ”€â”€ ë°”ì´ì˜¤ë§ˆì»¤ë³„ ë¶„ì„ ì„±ëŠ¥
â”‚   â”‚   â”œâ”€â”€ êµì°¨ë°˜ì‘ì„± ì‹œí—˜
â”‚   â”‚   â”œâ”€â”€ ê°„ì„­ ì‹œí—˜
â”‚   â”‚   â””â”€â”€ ì¸¡ì • ë²”ìœ„ (Reportable Range)
â”‚   â”œâ”€â”€ 03-clinical-performance.md            # ì„ìƒ ì„±ëŠ¥ í‰ê°€
â”‚   â”‚   â”œâ”€â”€ ì„ìƒì‹œí—˜ í”„ë¡œí† ì½œ
â”‚   â”‚   â”œâ”€â”€ ëŒ€ì¡° ë°©ë²• ë¹„êµ (ê¸°ì¡´ IVD ê¸°ê¸°)
â”‚   â”‚   â””â”€â”€ ì„ìƒ ë¯¼ê°ë„/íŠ¹ì´ë„
â”‚   â”œâ”€â”€ 04-software-verification.md           # ì†Œí”„íŠ¸ì›¨ì–´ ê²€ì¦ ê²°ê³¼
â”‚   â”œâ”€â”€ 05-electrical-safety.md               # ì „ê¸° ì•ˆì „ (IEC 60601-1, ë¦¬ë”ê¸°)
â”‚   â”œâ”€â”€ 06-emc-testing.md                     # EMC ì‹œí—˜ (IEC 60601-1-2, ë¦¬ë”ê¸°)
â”‚   â”œâ”€â”€ 07-biocompatibility.md                # ìƒì²´ì í•©ì„± (ISO 10993, ë¦¬ë”ê¸°)
â”‚   â”œâ”€â”€ 08-stability-testing.md               # ì•ˆì •ì„± ì‹œí—˜ (ì¹´íŠ¸ë¦¬ì§€ ìœ íš¨ê¸°ê°„)
â”‚   â”œâ”€â”€ 09-usability-testing.md               # ì‚¬ìš©ì í•©ì„± ì‹œí—˜ (IEC 62366-1)
â”‚   â””â”€â”€ 10-cybersecurity-testing.md           # ì‚¬ì´ë²„ë³´ì•ˆ ì‹œí—˜ (ì¹¨íˆ¬ í…ŒìŠ¤íŠ¸ ë“±)
â”‚
â”œâ”€â”€ 06-cybersecurity/                         # ì‚¬ì´ë²„ë³´ì•ˆ
â”‚   â”œâ”€â”€ 01-threat-model.md                    # â†’ ê¸°ì¡´ STRIDE ë¬¸ì„œ ì°¸ì¡°
â”‚   â”œâ”€â”€ 02-sbom.md                            # ì†Œí”„íŠ¸ì›¨ì–´ BOM (CycloneDX)
â”‚   â”œâ”€â”€ 03-vulnerability-management.md        # ì·¨ì•½ì  ê´€ë¦¬ í”„ë¡œì„¸ìŠ¤
â”‚   â”œâ”€â”€ 04-security-update-plan.md            # ë³´ì•ˆ ì—…ë°ì´íŠ¸ ê³„íš
â”‚   â””â”€â”€ 05-incident-response-plan.md          # â†’ ê¸°ì¡´ STRIDE ë¬¸ì„œ ì°¸ì¡°
â”‚
â”œâ”€â”€ 07-data-protection/                       # ë°ì´í„° ë³´í˜¸
â”‚   â”œâ”€â”€ 01-data-protection-policy.md          # â†’ ê¸°ì¡´ ì™„ë£Œ ë¬¸ì„œ ì°¸ì¡°
â”‚   â”œâ”€â”€ 02-dpia.md                            # ë°ì´í„° ë³´í˜¸ ì˜í–¥í‰ê°€ (GDPR Art.35)
â”‚   â”œâ”€â”€ 03-consent-management-spec.md         # ë™ì˜ ê´€ë¦¬ ìƒì„¸ ì‚¬ì–‘
â”‚   â””â”€â”€ 04-data-localization-plan.md          # êµ­ê°€ë³„ ë°ì´í„° í˜„ì§€í™” ê³„íš
â”‚
â”œâ”€â”€ 08-labeling/                              # ë¼ë²¨ë§ ë° IFU
â”‚   â”œâ”€â”€ 01-labeling-artwork.md                # ë¼ë²¨ ë””ìì¸
â”‚   â”œâ”€â”€ 02-ifu-instructions.md                # ì‚¬ìš©ì„¤ëª…ì„œ (Instructions for Use)
â”‚   â”œâ”€â”€ 03-quick-start-guide.md               # ë¹ ë¥¸ ì‹œì‘ ê°€ì´ë“œ
â”‚   â””â”€â”€ translations/                         # ë‹¤êµ­ì–´ ë²ˆì—­ (ko, en, ja, zh, de, fr)
â”‚
â”œâ”€â”€ 09-clinical-evidence/                     # ì„ìƒ ê·¼ê±° (CE-IVDR)
â”‚   â”œâ”€â”€ 01-literature-review.md               # ë¬¸í—Œ ì¡°ì‚¬
â”‚   â”œâ”€â”€ 02-clinical-investigation-plan.md     # ì„ìƒì‹œí—˜ ê³„íšì„œ
â”‚   â”œâ”€â”€ 03-clinical-investigation-report.md   # ì„ìƒì‹œí—˜ ë³´ê³ ì„œ
â”‚   â””â”€â”€ 04-clinical-performance-summary.md    # ì„ìƒ ì„±ëŠ¥ ìš”ì•½ (SSCP for IVDR)
â”‚
â”œâ”€â”€ 10-post-market/                           # ì‹œíŒ í›„ ê´€ë¦¬
â”‚   â”œâ”€â”€ 01-pms-plan.md                        # ì‹œíŒ í›„ ê°ì‹œ ê³„íš
â”‚   â”œâ”€â”€ 02-pmpf-plan.md                       # ì‹œíŒ í›„ ì„±ëŠ¥ ì¶”ì  ê³„íš (IVDR)
â”‚   â”œâ”€â”€ 03-psur-template.md                   # ì£¼ê¸°ì  ì•ˆì „ ì—…ë°ì´íŠ¸ ë³´ê³  ì–‘ì‹
â”‚   â”œâ”€â”€ 04-vigilance-reporting.md             # ì˜ë£Œê¸°ê¸° ì´ìƒì‚¬ë¡€ ë³´ê³  ì ˆì°¨
â”‚   â””â”€â”€ 05-field-safety-corrective-action.md  # í˜„ì¥ ì•ˆì „ ì‹œì • ì¡°ì¹˜ ì ˆì°¨
â”‚
â””â”€â”€ 11-regulatory-submissions/                # ì¸í—ˆê°€ ì œì¶œ ë¬¸ì„œ
    â”œâ”€â”€ kr-mfds/                              # í•œêµ­ MFDS í—ˆê°€ ì„œë¥˜
    â”‚   â”œâ”€â”€ application-form.md
    â”‚   â””â”€â”€ country-specific-requirements.md
    â”œâ”€â”€ us-fda/                               # ë¯¸êµ­ FDA 510(k)
    â”‚   â”œâ”€â”€ 510k-cover-letter.md
    â”‚   â”œâ”€â”€ substantial-equivalence.md
    â”‚   â”œâ”€â”€ predicate-device-comparison.md
    â”‚   â””â”€â”€ level-of-concern.md
    â”œâ”€â”€ eu-ivdr/                              # EU CE-IVDR
    â”‚   â”œâ”€â”€ declaration-of-conformity.md
    â”‚   â”œâ”€â”€ gspr-checklist.md                 # General Safety & Performance Requirements
    â”‚   â””â”€â”€ udi-registration.md
    â”œâ”€â”€ cn-nmpa/                              # ì¤‘êµ­ NMPA
    â”‚   â”œâ”€â”€ registration-application.md
    â”‚   â””â”€â”€ cybersecurity-report.md
    â””â”€â”€ jp-pmda/                              # ì¼ë³¸ PMDA
        â”œâ”€â”€ certification-application.md
        â””â”€â”€ essential-principles.md
```

---

## 2. FDA 510(k) ì œì¶œ ë¬¸ì„œ êµ¬ì¡° (ìƒì„¸)

| ì„¹ì…˜ | ë¬¸ì„œ | ê·¼ê±° | ì†ŒìŠ¤ |
|------|------|------|------|
| I | Cover Letter | 21 CFR 807.87 | ì‹ ê·œ ì‘ì„± |
| II | Indications for Use | 21 CFR 807.87(e) | `01-device-description/01-product-overview.md` |
| III | 510(k) Summary or Statement | 21 CFR 807.92 | ì‹ ê·œ ì‘ì„± |
| IV | Truthful and Accuracy Statement | 21 CFR 807.87 | ì„œëª… í•„ìš” |
| V | Device Description | 21 CFR 807.87(e) | `01-device-description/*` |
| VI | Substantial Equivalence | 21 CFR 807.87(f) | `11-regulatory-submissions/us-fda/substantial-equivalence.md` |
| VII | Performance Data | 21 CFR 807.87(g) | `05-verification-and-validation/02-analytical-performance.md` |
| VIII | Software Documentation | FDA SW Guidance | `03-software-documentation/*` |
| IX | Cybersecurity Documentation | FDA Cyber 2023 | `06-cybersecurity/*` |
| X | Labeling | 21 CFR 809.10 | `08-labeling/*` |
| XI | Biocompatibility | ISO 10993 | `05-verification-and-validation/07-biocompatibility.md` |
| XII | EMC/Electrical Safety | IEC 60601 | `05-verification-and-validation/05,06` |

---

## 3. CE-IVDR Technical Documentation (Annex II/III) ë§¤í•‘

| IVDR Annex | ë‚´ìš© | ëŒ€ì‘ ì„¹ì…˜ |
|------------|------|---------|
| Annex II, 1 | ê¸°ê¸° ì„¤ëª… ë° ì‚¬ì–‘ | `01-device-description/` |
| Annex II, 2 | ì œì¡° ì •ë³´ | `02-design-and-manufacturing/06` |
| Annex II, 3 | ì„¤ê³„/ì œì¡° ì •ë³´ | `02-design-and-manufacturing/` + `03-software-documentation/` |
| Annex II, 4 | GSPR (Annex I) | `11-regulatory-submissions/eu-ivdr/gspr-checklist.md` |
| Annex II, 5 | ìœ„í—˜-í¸ìµ ë¶„ì„ | `04-risk-management/` |
| Annex II, 6 | ì œí’ˆ ê²€ì¦/í™•ì¸ | `05-verification-and-validation/` |
| Annex III | ê¸°ìˆ ë¬¸ì„œ (ì„±ëŠ¥ í‰ê°€) | `09-clinical-evidence/` |
| Annex XIII | ì„±ëŠ¥ ì—°êµ¬ | `09-clinical-evidence/02-clinical-investigation-plan.md` |

---

## 4. í˜„ì¬ ì™„ë£Œ ë¬¸ì„œ ë§¤í•‘

| ê¸°ìˆ ë¬¸ì„œ ì„¹ì…˜ | ê¸°ì¡´ ì™„ë£Œ ë¬¸ì„œ | ì¶”ê°€ ì‘ì—… í•„ìš” |
|-------------|-------------|-------------|
| 03-04 (ì•ˆì „ ë“±ê¸‰) | `docs/compliance/software-safety-classification.md` | âŒ ì™„ë£Œ |
| 03-05 (ì„œë¸Œì‹œìŠ¤í…œ ë“±ê¸‰) | ìœ„ ë¬¸ì„œ ì„¹ì…˜ 5 | âŒ ì™„ë£Œ |
| 06-01 (STRIDE) | `docs/security/stride-threat-model.md` | ğŸ”„ DFD ë³´ì™„ |
| 06-05 (IRP) | ìœ„ ë¬¸ì„œ ì„¹ì…˜ 5 | âŒ ì™„ë£Œ |
| 07-01 (ë°ì´í„° ë³´í˜¸) | `docs/compliance/data-protection-policy.md` | ğŸ”„ DPIA ì¶”ê°€ |
| 04 (ìœ„í—˜ê´€ë¦¬) | ëª©ì°¨ë§Œ ì¡´ì¬ | ğŸ”´ ì‹¤ì²´ ë¬¸ì„œ ì‘ì„± í•„ìš” |
| ê¸°íƒ€ ì „ì²´ | - | ğŸ”´ ëŒ€ë¶€ë¶„ ë¯¸ì°©ìˆ˜ |

---

**Document Version**: 1.0.0
**ì‘ì„±ì¼**: 2026-02-09
**ì‘ì„±ì**: Claude (Regulatory & Security Analysis)
